Senior Principal Scientist, Large Molecule ML Translation, AI for Drug Discovery (AIDD)
Genentech, Inc. - South San Francisco, California, United States of America
Posted Nov 17, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Offered From the posting source checked Nov 19, 2026
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified checked Nov 20, 2026
- Salary
- $238K-$441K From the posting source checked Nov 19, 2026
- 401(k) match
- Reported from DOL Form 5500 industry filing (not employer-specific)
Was this benefit information wrong? Tell us.
Role
- Seniority
- Principal From the posting source checked Nov 19, 2026
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Senior Principal Scientist, Large Molecule ML Translation, AI for Drug Discovery (AIDD) South San Francisco, California, United States of America The Position A healthier future. It's what drives us to innovate. To continuously advance science and ensure everyone has access to the healthcare they need today and for generations to come. Creating a world where we all have more time with the people we love. That's what makes us Roche. Advances in AI, data, and computational sciences are transforming drug discovery and development. Roche's Research and Early Development organisations at Genentech (gRED) and Pharma (pRED) have demonstrated how these technologies accelerate R&D, leveraging data and novel computational models to drive impact. Seamless data sharing and access to models across gRED and pRED are essential to maximising these opportunities. The new Computational Sciences Center of Excellence (CoE) is a strategic, unified group whose goal is to harness the transformative power of data and Artificial Intelligence (AI) to assist our scientists in both pRED and gRED to deliver more innovative and transformative medicines for patients worldwide. The Opportunity Roche's AI for Drug Discovery (AIDD) group, part of the Computational Sciences Center of Excellence, has built strong machine learning for large molecule discovery, including developability, functional modeling and design optimization. The hard part now is getting those methods into the programs that put molecules in the clinic. Today the methods are powerful but siloed. Some live in research code, some are run by hand by a few experts, and they're often aimed
Read the full description at roche.wd3.myworkdayjobs.com. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Senior Machine Learning Scientist, Protein ML, AI for Drug Discovery (AIDD)
Genentech, Inc. - South San Francisco, California, United States of America
Senior Principal Scientist, Applied AI & Agentic Systems for Small-Molecule Drug Discovery
Vertex Pharmaceuticals - Boston, MA
Principal Scientist, Translational AI Foundations
Bristol Myers Squibb - Cambridge Crossing - MA - US
Principal Scientist, AI / ML
Edwards Lifesciences - USA - California – Irvine